MNM Diagnostics is a diagnostics company based in Poland. We help people understand their genetic background through whole genome sequencing and advanced software tools for rapid and effective early disease diagnosis, prediction and prognosis. We believe that every person should have access to the information encoded in his/her DNA. By combining whole genome sequencing (WGS) technology with our unique algorithms, we decipher this information and create personalized diagnostics for individual patients. Our team of creative and enthusiastic people combines expertise in DNA chemistry and cell biology, with AI and machine learning to provide cutting-edge genome analysis and develop new approaches to personalised medicine. Knowing that information about how to fight patient’s disease is hidden in their genome, we help patients to recognise the cause of their disease and choose the right strategy to fight it.
Total Funding: €738 K
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2018
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at MNM Diagnostics
MNM Diagnostics - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
MNM Diagnostics - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started